The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.
Therapeutic drug monitoring of critical dose immunosuppressant drugs is established clinical practice and there are similar good reasons to monitor antiretrovirals. The aim of this article is to review the recent literature (last five years), with particular reference to the use of liquid chromatography-tandem mass spectrometry (LC-MS/MS). LC-MS/MS offers many potential advantages. The superior selectivity of LC-MS/MS over immunoassays for immunosuppressant drugs has been widely reported. Simultaneous measurement of a number of drugs can be performed. It is currently routine practice for the four major immunosuppressants (cyclosporin, tacrolimus, sirolimus and everolimus) to be simultaneously measured in whole blood. While up to 17 antiretroviral drugs have been simultaneously measured in plasma. The exquisite sensitivity of LC-MS/MS also provides the opportunity to measure these drugs in alternative matrices, such as dried blood spots, saliva, peripheral blood mononuclear cells and tissue. However, the clinical utility of measuring these classes of drugs in alternative matrices is still to be determined.
Taylor
Paul J
PJ
Department of Clinical Pharmacology, Princess Alexandra Hospital, Brisbane, QLD, Australia. p.taylor1@uq.edu.au
Tai
Chun-Hui
CH
Franklin
Michael E
ME
Pillans
Peter I
PI
D044966:Anti-Retroviral Agents / Q000032:analysis*; D002853:Chromatography, Liquid; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000032:analysis*; D053719:Tandem Mass Spectrometry
D044966:Anti-Retroviral Agents; D007166:Immunosuppressive Agents